ANO1 and gastrointestinal stromal tumor: In summary, these data suggest CTC detection by ANO1 as a potentially useful prognostic and predictive biomarker in GIST patients that may help to further stratify risk status within different stages of disease and to monitor the recurrence and metastasis.